Metabolix, Inc. to Present at Investor Conference
CAMBRIDGE, Mass., Feb 15, 2008 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on developing clean, sustainable solutions for the world's needs for plastics, fuels, and chemicals, today announced that it will be presenting at the Piper Jaffray Clean Tech and Renewables conference taking place on February 20, 2008 in New York City.
Dr. Oliver Peoples, the Company's Co-Founder and Chief Scientific Officer will be presenting on Wednesday, February 20, 2008 at 9:30 a.m. Eastern Time. The webcast can be accessed on the company's website at www.metabolix.com in the Investor Relations section under the Webcasts & Presentations tab.
For those unable to listen to the presentation live, the webcast will be archived and can be accessed from the Company's website.
About Metabolix
Founded in 1992, Metabolix, Inc. is an innovation driven bioscience company focused on providing sustainable solutions for the world's needs for plastics, fuels and chemicals. The Company is taking a systems approach, from gene to end product, integrating sophisticated biotechnology with advanced industrial practice. Metabolix is now developing and commercializing Mirel(TM) bioplastics, a sustainable and biodegradable alternative to petroleum based plastics. Mirel is suitable for injection molding, extrusion coating, cast film and sheet, blown film and thermoforming. Metabolix is also developing a proprietary platform technology for co-producing plastics, biofuels and chemical products in biomass energy crops such as switchgrass. For more information, please visit www.metabolix.com. (MBLX-G)
SOURCE: Metabolix, Inc.
Investor Relations: ICR Kathleen Heaney, 203-803-3585 ir@metabolix.com
Copyright Business Wire 2008
News Provided by COMTEX
